Tobramycin (Akorn, Inc.)


Welcome to the PulseAid listing for the Tobramycin drug offered from Akorn, Inc.. This Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Akorn, Inc.
NON-PROPRIETARY NAME: Tobramycin Sulfate
SUBSTANCE NAME: TOBRAMYCIN SULFATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2014-09-16
END MARKETING DATE: 0000-00-00


Tobramycin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTobramycin from Akorn, Inc.
LABELER NAME: Akorn, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 40(mg/mL)
START MARKETING DATE: 2014-09-16
END MARKETING DATE: 0000-00-00
PRODUCT ID: 17478-114_46f012c3-b6fa-40ce-86ce-320ceb3e84c8
PRODUCT NDC: 17478-114
APPLICATION NUMBER: ANDA205179

Other TOBRAMYCIN SULFATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Tobramycin
Claris Lifesciences Inc.Tobramycin
Fresenius Kabi USA, LLCTobramycin
Hospira, Inc.Tobramycin
Mylan Institutional LLCTobramycin
Pfizer Laboratories Div Pfizer IncTobramycin Sulfate
Teva Parenteral Medicines, Inc.Tobramycin
X-GEN Pharmaceuticals, Inc.Tobramycin
Xellia Pharmaceuticals ApSTobramycin